Zobrazeno 1 - 10
of 376
pro vyhledávání: ''
Autor:
S. Hazra, Zhong-Zhe Lin, Yen-Hsun Chen, Ghassan K. Abou-Alfa, Suvajit Sen, Tim Meyer, Rebecca A. Miksad, Jillian Youkstetter, Ann-Lii Cheng, Stefano Kim, Anthony B. El-Khoueiry, Irfan Cicin, Heinz-Josef Klümpen, Robin Kate Kelley
Publikováno v:
British journal of cancer, 126(4), 569-575. Nature Publishing Group
British Journal of Cancer, vol 126, iss 4
British Journal of Cancer, vol 126, iss 4
Background Albumin-bilirubin (ALBI) grade is an objective measure of liver function for patients with hepatocellular carcinoma (HCC). The tyrosine kinase inhibitor cabozantinib is approved for patients with advanced HCC who have received prior sorafe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff7d7aa6f342671f87fffbc132a97bdb
https://pure.amc.nl/en/publications/efficacy-and-safety-of-cabozantinib-for-patients-with-advanced-hepatocellular-carcinoma-based-on-albuminbilirubin-grade(6723e70d-57fc-46f8-80b0-a3460e6124cc).html
https://pure.amc.nl/en/publications/efficacy-and-safety-of-cabozantinib-for-patients-with-advanced-hepatocellular-carcinoma-based-on-albuminbilirubin-grade(6723e70d-57fc-46f8-80b0-a3460e6124cc).html
Autor:
Savtaj S. Brar, Carol Jane Swallow, Charles Henry Lim, Hao-Wen Sim, Jennifer J. Knox, Bryan A. Chan, Akina Natori, James Brierley, Osvaldo Espin-Garcia, Rebecca Wong, Jolie Ringash, Eric Chen, Elena Elimova, Sara Hafezi-Bakhtiari, John Kim, Raymond Woo-Jun Jang, Di Maria Jiang, Geoffrey Liu, Patrik Rogalla, Gail Darling, Stephanie Moignard
Publikováno v:
Oncology. 99:49-56
Background: Trimodality therapy (TMT) with neoadjuvant chemoradiotherapy (nCRT) using concurrent carboplatin plus paclitaxel (CP) followed by surgery is the standard of care for locoregional esophageal or gastroesophageal junction (GEJ) cancers. Alte
Autor:
Takeshi Yuasa, Kosuke Takemura, Gulanbar Amori, Philip G. Board, Kentaro Inamura, Junji Yonese, Fumitaka Koga
Publikováno v:
Targeted Oncology. 15:347-356
γ-Glutamyltransferase (GGT) is a marker of oxidative stress. Elevated serum GGT is linked to poor survival in various malignancies; however, there are no data on metastatic renal cell carcinoma (mRCC). Additionally, GGT expression in cancer tissues
Autor:
Suneel Mundle, Namphuong Tran, Toshitaka Shin, Kazuhiro Shibayama, Satoshi Fukasawa, Nobuaki Matsubara, Hiroyoshi Suzuki, Noriyuki Ohtake, Sumiko Kitani, Katsuyoshi Hashine, Karim Fizazi
Publikováno v:
Japanese Journal of Clinical Oncology
Background LATITUDE was a randomized, double-blind, international and phase 3 study of abiraterone acetate plus prednisone in patients with high-risk metastatic hormone-naïve prostate cancer. In the first interim analysis of LATITUDE (clinical cutof
Publikováno v:
Anticancer Research. 39:6871-6875
BACKGROUND/AIM The aim of the present study was to determine whether serum lactate dehydrogenase (LDH) levels before treatment could predict the disease-specific and event-free survival in adult patients with STS. PATIENTS AND METHODS A total of 142
Autor:
Masakazu Toi, Shigehira Saji, Nobuaki Sato, Takashi Morimoto, Takayuki Ueno, Norikazu Masuda, Hiroyuki Yasojima, Shinji Ohno, Chizuko Kanbayashi, Koji Kaneko, Hironobu Sasano, Satoshi Morita
Publikováno v:
Cancer Medicine, Vol 8, Iss 12, Pp 5468-5481 (2019)
Cancer Medicine
Cancer Medicine
Our aim was to investigate the efficacy and safety of initial neoadjuvant endocrine therapy with exemestane alone followed by tailored treatment, either continued exemestane monotherapy or exemestane plus docetaxel–cyclophosphamide (TC) combination
Autor:
Katsunori Shinozaki, Ichinosuke Hyodo, Mitsuru Sasako, Masanori Terashima, Kensei Yamaguchi, Kei Muro, Tomohiro Nishina, Kohei Shitara, Masahiro Tsuda, Eisuke Inoue, Shinichiro Nakamura, Narikazu Boku, Takako E. Nakajima, Hiroki Hara, Hiroyuki Arai
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 21, Pp 7673-7682 (2021)
Cancer Medicine, Vol 10, Iss 21, Pp 7673-7682 (2021)
Background In the JCOG1108/WJOG7312G trial, a combination (FLTAX) of 5‐fluorouracil (FU) /leucovorin (FL) and paclitaxel (PTX) did not show superiority in overall survival (OS) to FL in untreated patients with severe peritoneal metastasis of gastri
Autor:
Masafumi Taniwaki, Koji Izutsu, Tadao Ishida, Takaaki Chou, Takashi Watanabe, Kenshi Suzuki, Naokuni Uike, Kiyohiko Hatake, Kensei Tobinai, Yoshihisa Shumiya, Takayuki Ishikawa, Kazutaka Sunami, Kiyoshi Ando, Morio Matsumoto, Shuji Ozaki, Hirohiko Shibayama, Shinsuke Iida
Publikováno v:
Cancer Science
This multicenter, open‐label phase 1/2 study evaluated single‐agent carfilzomib in 50 heavily pretreated Japanese patients with relapsed/refractory multiple myeloma (median of five prior treatments). In phase 1, patients were dosed at three level
Publikováno v:
Thoracic Cancer, Vol 10, Iss 6, Pp 1395-1401 (2019)
Thoracic Cancer
Thoracic Cancer
e15559 Background: A small proportion of patients with advanced esophageal squamous cell carcinoma (ESCC) could benefit from immune checkpoint inhibitors, and reliable peripheral blood biomarkers for outcomes of anti-PD-1 immunotherapy were not ident
Autor:
Yoshiyuki Fujiwara, Hiroaki Saito, Naruo Tokuyasu, Joji Watanabe, Takuki Yagyu, Teruhisa Sakamoto, Keigo Ashida, Masataka Amisaki, Ei Uchinaka, Soichiro Honjo, Masaki Morimoto
Publikováno v:
Anticancer Research. 39:1441-1446
Background The albumin-bilirubin (ALBI) grade assesses the severity of liver dysfunction in patients with hepatocellular carcinoma. Herein we investigated the prognostic significance of the combination of the ALBI grade with serum carbohydrate antige